NBIX logo

Neurocrine Biosciences Inc

NBIX

NBIX: Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

more

Show NBIX Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recently reported changes by institutional investors

Quarterly net insider trading by NBIX's directors and management

Government lobbying spending instances

  • $780,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Health Issues Medicare/Medicaid
  • $780,000 Apr 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Health Issues Medicare/Medicaid
  • $700,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Health Issues Medicare/Medicaid
  • $790,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Health Issues Medicare/Medicaid
  • $790,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Health Issues Medicare/Medicaid
  • $900,000 Jun 13, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Health Issues Medicare/Medicaid
  • $730,000 Jun 13, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Health Issues Medicare/Medicaid
  • $720,000 Oct 20, 2021 Issue: None
  • $700,000 Jul 20, 2021 Issue: None
  • $590,000 Apr 20, 2021 Issue: None
  • $820,000 Jan 19, 2021 Issue: None
  • $480,000 Oct 19, 2020 Issue: None
  • $440,000 Jul 20, 2020 Issue: None
  • $440,000 Apr 20, 2020 Issue: None
  • $640,000 Jan 21, 2020 Issue: None
  • $60,000 Oct 21, 2019 Issue: Pharmacy
  • $60,000 Jul 22, 2019 Issue: Pharmacy
  • $60,000 Apr 22, 2019 Issue: Pharmacy
  • $60,000 Jan 22, 2019 Issue: Pharmacy
  • $60,000 Oct 22, 2018 Issue: Pharmacy
  • $60,000 Jul 20, 2018 Issue: Pharmacy
  • $60,000 Apr 20, 2018 Issue: Pharmacy
  • $60,000 Jan 22, 2018 Issue: Pharmacy
  • $60,000 Oct 20, 2017 Issue: Pharmacy
  • $60,000 Jul 20, 2017 Issue: Pharmacy
  • $10,000 Apr 24, 2017 Issue: Pharmacy
U.S. Patents

New patents grants

  • Patent Title: Treatment of congenital adrenal hyperplasia Aug. 22, 2023
  • Patent Title: Substituted pyrido[2,1-a]isoquinolines as vmat2 inhibitors Aug. 08, 2023
  • Patent Title: Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Aug. 01, 2023
  • Patent Title: Methods for the administration of certain vmat2 inhibitors May. 23, 2023
  • Patent Title: Processes for the preparation of uracil derivatives Oct. 04, 2022
  • Patent Title: Methods for the administration of certain vmat2 inhibitors Sep. 13, 2022
  • Patent Title: Treatment of congenital adrenal hyperplasia Apr. 26, 2022
  • Patent Title: High dosage valbenazine formulation and compositions, methods, and kits related thereto Apr. 26, 2022
  • Patent Title: [9,10-dimethoxy-3-(2-methylpropyl)-1h,2h,3h,4h,6h,7h,11bh-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto Jul. 06, 2021
  • Patent Title: Vmat2 inhibitor compounds and compositions thereof Jun. 22, 2021
  • Patent Title: Methods for the administration of certain vmat2 inhibitors Jun. 22, 2021
  • Patent Title: Compounds of formulas (vii), (viii), (ix), (xi), (xii), (xiii), and (xiv) as muscarinic receptor 4(m4) antagonists for treating neurological diseases Jun. 15, 2021
  • Patent Title: High dosage valbenazine formulation and compositions, methods, and kits related thereto Jun. 08, 2021
  • Patent Title: Methods for the administration of certain vmat2 inhibitors Jun. 08, 2021
  • Patent Title: Substituted triazoles and methods relating thereto Jun. 01, 2021
  • Patent Title: Methods for the administration of certain vmat2 inhibitors May. 04, 2021
  • Patent Title: Methods for the administration of certain vmat2 inhibitors Mar. 23, 2021
  • Patent Title: Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Mar. 09, 2021
  • Patent Title: Methods for the administration of certain vmat2 inhibitors Mar. 09, 2021
  • Patent Title: Synthetic methods for preparation of (s)-(2r,3r,11br)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1h-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb. 16, 2021
  • Patent Title: Methods for the administration of certain vmat2 inhibitors Feb. 09, 2021
  • Patent Title: Synthetic methods for preparation of (s)-(2r,3r,11br)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1h-pyrido[2,1,-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb. 02, 2021
  • Patent Title: Synthetic methods for preparation of (s)-(2r,3r,11br)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1h-pyrido[2,1,-a]isoquinolin-2-2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb. 02, 2021
  • Patent Title: Treatment of congenital adrenal hyperplasia Feb. 02, 2021
  • Patent Title: Methods for the administration of certain vmat2 inhibitors Dec. 29, 2020
  • Patent Title: Methods for the administration of certain vmat2 inhibitors Dec. 08, 2020
  • Patent Title: Methods for the administration of certain vmat2 inhibitors Dec. 08, 2020
  • Patent Title: Valbenazine salts and polymorphs thereof Dec. 01, 2020
  • Patent Title: Valbenazine salts and polymorphs thereof Dec. 01, 2020
  • Patent Title: Valbenazine salts and polymorphs thereof Nov. 24, 2020
  • Patent Title: Substituted triazoles and methods relating thereto Aug. 11, 2020
  • Patent Title: Processes for the preparation of uracil derivatives Dec. 03, 2019
  • Patent Title: Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Jul. 02, 2019
  • Patent Title: Substituted triazoles and methods relating thereto Nov. 27, 2018
  • Patent Title: Valbenazine salts and polymorphs thereof Sep. 04, 2018
  • Patent Title: [9,10-dimethoxy-3-(2-methylpropyl)-1h,2h,3h,4h,6h,7h,11bh-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto Jun. 05, 2018
  • Patent Title: Processes for the preparation of uracil derivatives Jan. 16, 2018
  • Patent Title: Pharmaceutical compositions comprising an antipsychotic drug and a vmat2 inhibitor and uses thereof Oct. 10, 2017
  • Patent Title: Substituted triazoles and methods relating thereto Aug. 01, 2017
  • Patent Title: [9,10-dimethoxy-3-(2-methylpropyl)-1h,2h,3h,4h,6h,7h,11bh-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto Jul. 25, 2017
  • Patent Title: Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Aug. 23, 2016
  • Patent Title: Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Feb. 10, 2015
  • Patent Title: Processes for the preparation of uracil derivatives Jul. 01, 2014
  • Patent Title: Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Aug. 13, 2013
  • Patent Title: Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Jul. 09, 2013
  • Patent Title: Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol compounds and methods relating thereto Jan. 22, 2013
  • Patent Title: Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Sep. 11, 2012
  • Patent Title: Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Dec. 27, 2011
  • Patent Title: Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol compounds and methods relating thereto Oct. 18, 2011
  • Patent Title: Crf receptor antagonists and methods relating thereto Jan. 26, 2010
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of NBIX in WallStreetBets Daily Discussion

NBIX News

Recent insights relating to NBIX

CNBC Recommendations

Recent picks made for NBIX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NBIX

Corporate Flights

Flights by private jets registered to NBIX